SalesBook › Healthcare › Qure.ai
#11 in Healthcare · Global #66
Qure.ai
AI for medical imaging: FDA-cleared algorithms that read chest X-rays, head CTs and ultrasounds for TB, lung cancer, stroke and cardiac findings across 3,000+ sites.
Investors
Lightspeed Venture Partners360 ONE AssetNovo HoldingsHealthQuadTeamFundMerck Global Health Innovation FundKae CapitalMassMutual VenturesSequoia Capital
Sources
Every claim on this page links to where we found it. Profiles are checked from public sources and refreshed quarterly.
| Field | Claim | Source | Checked |
|---|---|---|---|
| Website | https://qure.ai | qure.ai | 2026-10-13 |
| Headquarters | Mumbai, India | accessdata.fda.gov | 2026-10-13 |
| Proof | FDA 510(k) K251934 qXR-Detect, decision 01/16/2026, applicant Qure.Ai Technologies | accessdata.fda.gov | 2026-10-13 |
| Proof | Company release: six new indications cleared; 26 FDA-cleared indications across 9 products (Feb 26 2026) | businesswire.com | 2026-10-13 |
| Claim | "3,000+ sites" figure not verified | not linked yet | 2026-10-13 |
Is this your company?
Show your SalesBook rank on your site, or fix a fact on this page. Updates are confirmed by an email link to your work address on qure.ai, then shown as updated by the company. The link proves someone can read a mailbox on that domain, not domain ownership or who they are; SalesBook does not independently check the new value. Ranks are never for sale.